Ezra Cohen

Title: Ezra Cohen: Innovator in Neoantigen Identification

Introduction

Ezra Cohen is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer research, particularly in the identification of neoantigens. His innovative work aims to enhance the effectiveness of engineered immune cells in targeting cancer cells.

Latest Patents

Cohen holds a patent for "Methods of neoantigen identification." This patent describes systems and methods for identifying neoantigen peptide candidates. Such systems can be utilized to generate engineered immune cells that specifically target neoantigen peptides. Notably, these methods do not require in silico epitope binding prediction algorithms. Additionally, they can identify neoantigens for cancers or tumors with a low mutational burden.

Career Highlights

Throughout his career, Ezra Cohen has focused on advancing cancer treatment methodologies. His work has been instrumental in developing new strategies for immune cell engineering. With a patent count of 1 patent, he continues to push the boundaries of cancer research.

Collaborations

Cohen has collaborated with notable researchers in the field, including Stephen P Schoenberger and Bjoern Peters. These partnerships have further enriched his research and contributed to the advancement of neoantigen identification techniques.

Conclusion

Ezra Cohen's innovative work in neoantigen identification represents a significant advancement in cancer research. His contributions are paving the way for more effective cancer treatments and engineered immune cell therapies.